Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta‐analysis

Abstract Defibrillation threshold (DFT) testing has been an integral part of implantable cardioverter‐defibrillator (ICD) implantation to confirm appropriate sensing of ventricular fibrillation and to establish an adequate safety margin for defibrillation. However, there is a lack of evidence regard...

Full description

Bibliographic Details
Published in:	Journal of Arrhythmia
Main Authors:	Munish Kannabhiran, Usman Mustafa, Madan Acharya, Nelson Telles, Brackett Alexandria, Pratap Reddy, Paari Dominic
Format:	Article
Language:	English
Published:	Wiley 2018-12-01
Subjects:	defibrillation testing DFT ICD implantable cardioverter defibrillator mortality
Online Access:	https://doi.org/10.1002/joa3.12109

Similar Items

Sex differences in ICDs for primary prevention: Time to include women in ICD trials!
by: Luisa Allen Ciuffo, et al.
Published: (2022-04-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy
by: Alexander Niedermeier, et al.
Published: (2021-12-01)

An inappropriately–appropriate ICD therapy: What is the mechanism and what interventions can be done?
by: Athanasios Saplaouras, et al.
Published: (2023-10-01)

How does the ICD recognize the type of arrhythmia? Tachyarrhythmia discrimination in modern transvenous cardioverter defibrillators
by: Flóra Diána Gausz, et al.
Published: (2025-08-01)

S-ICD Implantation "Tips and Tricks"
by: Szymon Budrejko, et al.
Published: (2023-07-01)

ICD Outcome in Pediatric Cardiomyopathies
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)

High Defibrillation Threshold: The Science, Signs and Solutions
by: Sony Jacob, et al.
Published: (2010-01-01)

IMPLANTATION OF AN ICD AND DFT TESTING IN PATIENT WITH PERSISTENT LEFT SUPERIOR VENA CAVA
by: Tomislav Kostic, et al.
Published: (2015-04-01)

The VDD ICD lead: Friend or Foe?
by: Suneet Mittal, MD
Published: (2020-07-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya
by: Emmanuel Oluoch, et al.
Published: (2024-08-01)

Bioelectrical impedance analysis of body composition: influence of a newly implanted cardiac device
by: Pinto Luiz Wellington, et al.
Published: (2017-07-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN‐ICD/WCD study): Rationale and design of a prospective, multicenter, observational, comparative study
by: Yukitoshi Ikeya, et al.
Published: (2024-06-01)

Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
by: Sem Briongos‐Figuero, et al.
Published: (2020-02-01)

Relevance of guideline-based ICD indications to clinical practice
by: Nora Al-Jefairi, et al.
Published: (2014-01-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD
by: Alessandro Corzani, et al.
Published: (2015-01-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Contemporary Management and Prognostic Factors of Arrhythmia Recurrence in Patients with High-Energy Discharge of Cardiac Implantable Electronic Devices
by: Zofia Kampka, et al.
Published: (2024-10-01)

Periprocedural decrease in tumor necrosis factor alpha is a risk factor for atrial fibrillation recurrence after ablation
by: Ewa Szczerba, et al.
Published: (2022-12-01)

“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators
by: Carroll SL, et al.
Published: (2018-09-01)

Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)

Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease
by: Rohit J. Timal, et al.
Published: (2025-04-01)

Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients
by: Arun Raghav Mahankali Sridhar, et al.
Published: (2016-09-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker
by: Paul S.G. Hong, MRCP, et al.
Published: (2015-01-01)

Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter‐Defibrillator: A Systematic Review and Meta‐Analysis
by: Usman Mustafa, et al.
Published: (2018-11-01)

Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
by: Javier Jiménez-Candil, et al.
Published: (2021-05-01)

Sudden cardiac arrest in a shockable rhythm induced by energy drinks: a case report
by: Małgorzata Kaszuba, et al.
Published: (2024-09-01)

Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures
by: Thomas F. Deering, et al.
Published: (2022-12-01)

Management of S‐ICD lead in a patient requiring sternotomy
by: Basil Saour, et al.
Published: (2019-07-01)